Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
13855 | 808 | 30.9 | 50% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
0 | 4 | BIOCHEMISTRY & MOLECULAR BIOLOGY//CELL BIOLOGY//ONCOLOGY | 4064930 |
236 | 3 | ADENOSINE//NUCLEOSIDES NUCLEOTIDES & NUCLEIC ACIDS//ADENOSINE RECEPTORS | 48331 |
1752 | 2 | LESCH NYHAN SYNDROME//AMP DEAMINASE//LESCH NYHAN DISEASE | 6485 |
13855 | 1 | 5 NUCLEOTIDASE//CN II//PYRIMIDINE 5 NUCLEOTIDASE | 808 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | 5 NUCLEOTIDASE | authKW | 750685 | 11% | 22% | 92 |
2 | CN II | authKW | 456176 | 2% | 93% | 13 |
3 | PYRIMIDINE 5 NUCLEOTIDASE | authKW | 314912 | 1% | 83% | 10 |
4 | PYRIMIDINE 5 NUCLEOTIDASE DEFICIENCY | authKW | 120926 | 0% | 80% | 4 |
5 | AMP HYDROLYSIS | authKW | 113370 | 0% | 100% | 3 |
6 | ERYTHROCYTE PYRIMIDINE 5 NUCLEOTIDASE P5N | authKW | 113370 | 0% | 100% | 3 |
7 | PYRIMIDINE NUCLEOTIDASE | authKW | 113370 | 0% | 100% | 3 |
8 | CYTOSOLIC 5 NUCLEOTIDASE II | authKW | 85026 | 0% | 75% | 3 |
9 | 5 3 DEOXYRIBONUCLEOTIDASE | authKW | 75580 | 0% | 100% | 2 |
10 | 5 NUCLEOTIDASE EC 3135 | authKW | 75580 | 0% | 100% | 2 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Biochemistry & Molecular Biology | 2466 | 47% | 0% | 376 |
2 | Biophysics | 646 | 11% | 0% | 90 |
3 | Hematology | 498 | 8% | 0% | 67 |
4 | Cell Biology | 209 | 10% | 0% | 82 |
5 | Medical Laboratory Technology | 180 | 3% | 0% | 22 |
6 | Medicine, Research & Experimental | 171 | 7% | 0% | 53 |
7 | CYTOLOGY & HISTOLOGY | 116 | 1% | 0% | 5 |
8 | Neurosciences | 73 | 8% | 0% | 66 |
9 | Toxicology | 33 | 3% | 0% | 22 |
10 | Biochemical Research Methods | 28 | 3% | 0% | 24 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | 44 KAGAMIYAMA 1CHOME | 37790 | 0% | 100% | 1 |
2 | BIOZENTRUM AK NEUROCHEM ZOOL | 37790 | 0% | 100% | 1 |
3 | CNRSMOL STRUCT BASES INFECT DIS UMR 5086 | 37790 | 0% | 100% | 1 |
4 | DIPARTIMENTO SCI FARMACAO | 37790 | 0% | 100% | 1 |
5 | ENSCMIBMM | 37790 | 0% | 100% | 1 |
6 | GERIATR UNITSAKYO KU | 37790 | 0% | 100% | 1 |
7 | IMB UMR ESTBB 5251 | 37790 | 0% | 100% | 1 |
8 | INSERM 1052CNRS 5286 | 37790 | 0% | 100% | 1 |
9 | INSERM CNRS UMR U1052 5286 | 37790 | 0% | 100% | 1 |
10 | INVESTIGAC BIOMED ALBERTO SOLS UAM | 37790 | 0% | 100% | 1 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | INTERNATIONAL JOURNAL OF BIOCHEMISTRY | 4477 | 2% | 1% | 19 |
2 | ENZYME | 4042 | 1% | 1% | 9 |
3 | BIOCHEMICAL JOURNAL | 3315 | 6% | 0% | 51 |
4 | ATLA-ALTERNATIVES TO LABORATORY ANIMALS | 2745 | 1% | 1% | 10 |
5 | BIOCHIMICA ET BIOPHYSICA ACTA | 1659 | 4% | 0% | 36 |
6 | CANADIAN JOURNAL OF BIOCHEMISTRY | 1309 | 0% | 1% | 4 |
7 | COMPARATIVE BIOCHEMISTRY AND PHYSIOLOGY B-BIOCHEMISTRY & MOLECULAR BIOLOGY | 1122 | 2% | 0% | 17 |
8 | BULLETIN OF MOLECULAR BIOLOGY AND MEDICINE | 1116 | 0% | 1% | 2 |
9 | BULLETIN OF THE JAPANESE SOCIETY OF SCIENTIFIC FISHERIES | 715 | 1% | 0% | 6 |
10 | BIOCHEMICAL AND MOLECULAR MEDICINE | 631 | 0% | 1% | 2 |
Author Key Words |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | ZIMMERMANN, H , (1992) 5'-NUCLEOTIDASE - MOLECULAR-STRUCTURE AND FUNCTIONAL-ASPECTS.BIOCHEMICAL JOURNAL. VOL. 285. ISSUE . P. 345-365 | 114 | 54% | 476 |
2 | HUNSUCKER, SA , MITCHELL, BS , SPYCHALA, J , (2005) THE 5 '-NUCLEOTIDASES AS REGULATORS OF NUCLEOTIDE AND DRUG METABOLISM.PHARMACOLOGY & THERAPEUTICS. VOL. 107. ISSUE 1. P. 1-30 | 97 | 43% | 150 |
3 | ITOH, R , (2013) ENZYMATIC PROPERTIES AND PHYSIOLOGICAL ROLES OF CYTOSOLIC 5 '-NUCLEOTIDASE II.CURRENT MEDICINAL CHEMISTRY. VOL. 20. ISSUE 34. P. 4260-4284 | 63 | 62% | 4 |
4 | MAGNI, G , AMICI, A , ORSOMANDO, G , (2013) THE ENZYMOLOGY OF CYTOSOLIC PYRIMIDINE 5 '-NUCLEOTIDASES: FUNCTIONAL ANALYSIS AND PHYSIOPATHOLOGICAL IMPLICATIONS.CURRENT MEDICINAL CHEMISTRY. VOL. 20. ISSUE 34. P. 4304-4316 | 58 | 65% | 2 |
5 | ZANELLA, A , ZANELLA, A , FERMO, E , VALENTINI, G , (2006) HEREDITARY PYRIMIDINE 5 '-NUCLEOTIDASE DEFICIENCY: FROM GENETICS TO CLINICAL MANIFESTATIONS.BRITISH JOURNAL OF HAEMATOLOGY. VOL. 133. ISSUE 2. P. 113-123 | 51 | 84% | 15 |
6 | CORRONS, JLVI , (2000) CHRONIC NON-SPHEROCYTIC HAEMOLYTIC ANAEMIA DUE TO CONGENITAL PYRIMIDINE 5 ' NUCLEOTIDASE DEFICIENCY: 25 YEARS LATER.BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY. VOL. 13. ISSUE 1. P. 103 -118 | 47 | 85% | 4 |
7 | CHIARELLI, LR , FERMO, E , ZANELLA, A , VALENTINI, G , (2006) HEREDITARY ERYTHROCYTE PYRIMIDINE 5 '-NUCLEOTIDASE DEFICIENCY: A BIOCHEMICAL, GENETIC AND CLINICAL OVERVIEW.HEMATOLOGY. VOL. 11. ISSUE 1. P. 67-72 | 35 | 88% | 9 |
8 | BIANCHI, V , SPYCHALA, J , (2003) MAMMALIAN 5 '-NUCLEOTIDASES.JOURNAL OF BIOLOGICAL CHEMISTRY. VOL. 278. ISSUE 47. P. 46195-46198 | 35 | 80% | 126 |
9 | BRETONNET, AS , JORDHEIM, LP , DUMONTET, C , LANCELIN, JM , (2005) REGULATION AND ACTIVITY OF CYTOSOLIC 5 '-NUCLEOTIDASE II - A BIFUNCTIONAL ALLOSTERIC ENZYME OF THE HALOACID DEHALOGENASE SUPERFAMILY INVOLVED IN CELLULAR METABOLISM.FEBS LETTERS. VOL. 579. ISSUE 16. P. 3363-3368 | 39 | 78% | 16 |
10 | JORDHEIM, LP , CHALOIN, L , (2013) THERAPEUTIC PERSPECTIVES FOR CN-II IN CANCER.CURRENT MEDICINAL CHEMISTRY. VOL. 20. ISSUE 34. P. 4292-4303 | 40 | 56% | 2 |
Classes with closest relation at Level 1 |